You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/7906
Title: 
Blockade of fear-induced antinociception with intra-amygdala infusion of midazolam: Influence of prior test experience
Author(s): 
Institution: 
  • Universidade Federal de São Carlos (UFSCar)
  • Universidade Estadual Paulista (UNESP)
ISSN: 
0006-8993
Sponsorship: 
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Sponsorship Process Number: 
  • FAPESP: 06/06855-4
  • CNPq: 309407/2006-0
Abstract: 
Intra-amygdala infusion of midazolam, a benzodiazepine receptor agonist, produces anxiolytic-like effects in mice when first exposed to the elevated plus-maze (EPM) and blocks antinociception induced in mice confined in the open arm of the EPM. However, benzodiazepines fail to alter anxiety in maze-experienced rodents, a phenomenon defined as "one-trial tolerance" (OTT). The main purpose of the present study was to investigate whether intra-amygdala midazolam attenuates the open ann-induced antinociception (OAA) in maze-experienced mice. Nociception was assessed by the writhing test (intraperitoneal injection of 0.6% acetic acid). In Experiment 1, nociception was recorded in maze-experienced mice without prior drug treatment. Experiment 2 investigated the effects of systemic midazolam (0.5, 1.0 and 2.0 mg/kg, s.c.), injected before EPM trial 2, on OAA in maze-experienced mice. in Experiment 3, the effects on OAA of intra-amygdala midazolam (30 nmol/0.1 mu l), injected before trial 1 (maze-naive) or before trial 2 (maze-experienced), were observed. The effects on OAA of intra-amygdala midazolam injected before trial 1 and trial 2 were also investigated (Experiment 4). The results showed that OAA remained unchanged in maze-experienced mice and was insensitive to systemic midazolam. However, intra-amygdala midazolam attenuated OAA in maze-naive mice, but not in maze-experienced mice. Even when given before both trial 1 and trial 2, intra-amygdala midazolam failed to alter OAA in maze-experienced mice. Taken together, these results confirm that the GABA(A)/benzodiazepine receptor complex located within the amygdala plays a role in OAA in maze-naive mice. The lack of effects following systemic or intra-amygdala midazolam on OAA in maze-experienced mice suggests that the OTT is also observed in the modulation of nociception and that the GABA(A)/benzodiazepine receptor located within this limbic forebrain structure participates in this process. (C) 2009 Elsevier B.V. All rights reserved.
Issue Date: 
6-Oct-2009
Citation: 
Brain Research. Amsterdam: Elsevier B.V., v. 1294, p. 29-37, 2009.
Time Duration: 
29-37
Publisher: 
Elsevier B.V.
Keywords: 
  • Fear
  • Antinociception
  • Amygdala
  • Midazolam
  • Elevated plus-maze
  • Mice
Source: 
http://dx.doi.org/10.1016/j.brainres.2009.07.055
URI: 
Access Rights: 
Acesso restrito
Type: 
outro
Source:
http://repositorio.unesp.br/handle/11449/7906
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.